Reply by Authors (2021)

No AccessJournal of UrologyAdult Urology1 May 2021Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Nitin K. Yerram, Lori Long, Luke P. O’Connor, Alex Z. Wang, Michael Ahdoot, Amir H. Lebastchi, Sandeep Gurram, Johnathan Zeng, Heather Chalfin, Stephanie A. Harmon, Sherif Mehralivand, Maria J. Merino, Howard L. Parnes, Peter L. Choyke, Joanna Shih, Bradford J. Wood, Baris Turkbey, and Peter A. Pinto Nitin K. YerramNitin K. Yerram *Correspondence: Center for Cancer Research, National Cancer Institute, Building 10, Hatfield CRC, Room 2W-5940, Bethesda, Maryland 20892 telephone: 301-642-2814; E-mail Address: [email protected] Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Lori LongLori Long Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Luke P. O’ConnorLuke P. O’Connor Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Alex Z. WangAlex Z. Wang Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Michael AhdootMichael Ahdoot Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Amir H. LebastchiAmir H. Lebastchi Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Sandeep GurramSandeep Gurram Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Johnathan ZengJohnathan Zeng Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Heather ChalfinHeather Chalfin Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Stephanie A. HarmonStephanie A. Harmon Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland More articles by this author , Sherif MehralivandSherif Mehralivand Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Maria J. MerinoMaria J. Merino Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Howard L. ParnesHoward L. Parnes Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Peter L. ChoykePeter L. Choyke Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , Joanna ShihJoanna Shih Division of Cancer Prevention, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland More articles by this author , Bradford J. WoodBradford J. Wood Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Financial interest and/or other relationship with NVIDIA and NIH (which has cooperative research and development agreements with Philips, Celsion Corp., Boston Scientific, Siemens and Exact Robotics, and MTA support with Exact Imaging, Canon Medical, QT Imaging and Angiodynamics). More articles by this author , Baris TurkbeyBaris Turkbey Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author , and Peter A. PintoPeter A. Pinto Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001547.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 205(5), pp. 1359–1360 Reference 1. : 17-Gene genomic prostate score test results in the Canary Prostate Active Surveillance Study (PASS) cohort. J Clin Oncol 2020; 38: 1549. Google Scholar © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyMar 11, 2021, 12:00:00 AMEditorial CommentJournal of UrologyMar 11, 2021, 12:00:00 AMEditorial Comment Volume 205Issue 5May 2021Page: 1359-1360 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nitin K. Yerram Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland *Correspondence: Center for Cancer Research, National Cancer Institute, Building 10, Hatfield CRC, Room 2W-5940, Bethesda, Maryland 20892 telephone: 301-642-2814; E-mail Address: [email protected] More articles by this author Lori Long Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Luke P. O’Connor Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Alex Z. Wang Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Michael Ahdoot Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Amir H. Lebastchi Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Sandeep Gurram Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Johnathan Zeng Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Heather Chalfin Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Stephanie A. Harmon Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland More articles by this author Sherif Mehralivand Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Maria J. Merino Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Howard L. Parnes Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Peter L. Choyke Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Joanna Shih Division of Cancer Prevention, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland More articles by this author Bradford J. Wood Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Financial interest and/or other relationship with NVIDIA and NIH (which has cooperative research and development agreements with Philips, Celsion Corp., Boston Scientific, Siemens and Exact Robotics, and MTA support with Exact Imaging, Canon Medical, QT Imaging and Angiodynamics). More articles by this author Baris Turkbey Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Peter A. Pinto Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland More articles by this author Expand All Advertisement Loading ...